It is now recognized that MLL-rearranged (MLL-r) leukemias comprise approximately 10% of all human leukemias and mostly manifest as B-cell ALL, AML, and acute leukemia of ambiguous lineage [1, 2]. This evidence concerns the gene KMT2A and acute leukemia.